Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, announced today that on February 4, 2026 it entered into a Cooperation Framework Agreement (the "Agreement") with Tigerbone Group Limited ("Tigerbone Group").  As part of this strategic initiative, the parties also announced plans to establish the "BON Cooperation and Development Committee," which will serve as a central platform to advance collaboration in traditional Chinese medicine and life sciences through resource sharing and complementary strengths.

Pursuant to the Agreement, and based on principles of equality, voluntariness, resource sharing, complementary advantages, and mutual benefit, BON and Tigerbone Group will collaborate across traditional Chinese medicine products, life sciences research, and nutritional functional foods. Each party will retain its independent intellectual property rights and scientific research achievements, while jointly developing new products, technologies, and solutions to drive innovation and long-term value creation.